Premium Insights - page 4 | BiopharmaTrend

17 More Biomedical Foundation Models

MIT & Recursion's Boltz-2 just launched—here’s a quick scan of 15+ new models spanning chemistry, oncology, trials, and clinical workflows The latest addition arrived yesterday: Boltz-2, an open-source model from MIT …

Continue ›››

AI-Based Next-Generation-Phenotyping for Rare Disease Diagnosis

Rare diseases, which affect more than 300 million people worldwide, are often difficult to diagnose. Many patients wait five years or more for a correct diagnosis and are misdiagnosed at …

Continue ›››

14 Startups in AI Protein Design: Platforms, Specialists, Modular Tools

A Nobel, a venom cure, and a 200-million-protein database—by late 2024, AI design has earned recognition. David Baker from University of Washington collected the Nobel Prize in Chemistry for structure-guided engineering, sharing the honor …

Continue ›››

AI Meets Clinical Trials: Recent Policy Shifts & Companies to Watch

Today, clinical trials are longer and more data-heavy than a decade ago. At a time of regulatory rethinking, we trace how AI is beginning to orchestrate trial workflows. To know …

Continue ›››

The Infrastructure Layer: 30 Platforms Powering Human-Relevant Drug Development

Infrastructure for large-scale biomedical data — from multi-omics to EHRs — is converging with a growing policy and business case for data-native drug development. In this article: Clinical Data & Real-World …

Continue ›››

The Rise of AI Agents in Biotech, Where Are We Now?

There's been a growing buzz around “AI agents” across the tech ecosystem, with promises of autonomy, automation, and accelerated discovery. In biotech and drug development, however, their real-world presence is still early-stage. …

Continue ›››

23 New Startups in AI Drug Development Space Launched 2023–2025

A snapshot of emerging startups applying AI across the drug development pipeline—from molecular design to clinical decision support. AI began entering biomedical research in the 1970s through early initiatives like …

Continue ›››

13 Foundation Models: Startups, Industry Updates and the Nobel Prize

Since our previous overview of foundation models and start-ups in the life science field, a historical event took place on October 9th, 2024: the Nobel Prize in Chemistry was awarded to David Baker, Demis Hassabis, and John …

Continue ›››

12 Startups in the Digital Twin Healthcare Ecosystem: From Virtual Organs to Optimized Trials

Despite undeniable progress in life sciences over the last few decades, modern healthcare faces challenges on many fronts. Lengthy drug development processes, often spanning 10 to 15 years, suboptimal clinical …

Continue ›››

Next Generation Sequencing: New Tech and Companies to Watch

From the discovery of the double helix to the latest AI-driven innovations. In this article: Roche’s NGS Trajectory — Sequencing History — NGS in Healthcare — Notable Recent NGS Events — …

Continue ›››